Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KEEL | CHA |
|---|---|---|
| Price | $3.45 | $11.19 |
| Change today | ▼ 4.70% | ▲ 1.91% |
| Market cap | $2.13B | $2.13B |
| Return, 3 months | -22.3% | +0.9% |
| Return, year to date | +46.8% | -3.8% |
| Return, 1 year | -0.3% | -28.7% |
| P/E (TTM) | -4.6 | 10.7 |
| P/B | 6.5 | 1.7 |
| P/E percentile vs own 5y | 36th | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +4.0% |
| Net profit growth (YoY) | – | -52.8% |
| Gross margin | – | 45.8% |
| Operating margin | – | 10.4% |
| Net margin | – | 9.2% |
| Return on equity | – | – |
| Analyst target vs. price | +85.5% | +44.3% |
| Analyst buy share | 83% | 100% |
| RSI (14) | 45 | 45 |
| 30-day volatility | 77.8% | 47.6% |
| Max drawdown, 1 year | -73.6% | -44.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
